Schedule 13G ownership disclosure

DiaMedica Therapeutics Inc

Common Shares, no par value · CUSIP: 25253X207

Event date: 2025-07-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TomEnterprise AB

    Shares: 8,383,577.00 · Class: 16.28%

  • TomEnterprise Private AB

    Shares: 8,383,577.00 · Class: 16.28%

  • Thomas von Koch

    Shares: 8,383,577.00 · Class: 16.28%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-072272
Form type
SCHEDULE 13G/A
Filer
DiaMedica Therapeutics Inc.
CIK
CIK 1401040
Filed
Jul 30, 2025
Reporting period
Jul 23, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub